{"name":"Istituto Auxologico Italiano","slug":"istituto-auxologico-italiano","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"AD981","genericName":"AD981","slug":"ad981","indication":"Other","status":"phase_2"},{"name":"AD128","genericName":"AD128","slug":"ad128","indication":"Other","status":"phase_2"},{"name":"enalapril tablets","genericName":"enalapril tablets","slug":"enalapril-tablets","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Citalopram i.v. and p.o","genericName":"Citalopram i.v. and p.o","slug":"citalopram-i-v-and-p-o","indication":"Major depressive disorder","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Losartan Tablets","genericName":"Losartan Tablets","slug":"losartan-tablets","indication":"Hypertension","status":"marketed"}]}],"pipeline":[{"name":"AD981","genericName":"AD981","slug":"ad981","phase":"phase_2","mechanism":"AD981 is a small molecule that targets the [unknown] mechanism to treat [unknown] conditions.","indications":[],"catalyst":""},{"name":"AD128","genericName":"AD128","slug":"ad128","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Citalopram i.v. and p.o","genericName":"Citalopram i.v. and p.o","slug":"citalopram-i-v-and-p-o","phase":"phase_2","mechanism":"Selective serotonin reuptake inhibitor","indications":["Major depressive disorder"],"catalyst":""},{"name":"Losartan Tablets","genericName":"Losartan Tablets","slug":"losartan-tablets","phase":"marketed","mechanism":"Losartan blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure.","indications":["Hypertension","Diabetic nephropathy in patients with type 2 diabetes","Heart failure with reduced ejection fraction"],"catalyst":""},{"name":"enalapril tablets","genericName":"enalapril tablets","slug":"enalapril-tablets","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":5,"phaseCounts":{"phase_2":3,"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}